WHO ICTRP trial
Study on effect of Aspirin on permanent hemodialysis catheters patency rate
IRCT20221220056873N1 · Iranian Registry of Clinical Trials (IRCT) · Recruiting
Key facts
| Trial ID | IRCT20221220056873N1 |
|---|---|
| Public title | Study on effect of Aspirin on permanent hemodialysis catheters patency rate |
| Scientific title | Study on the effect of Aspirin on patency rate of permanent hemodialysis catheters in ESRD patients |
| Primary sponsor | Gorgan University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Recruiting |
| Study type | interventional |
| Phase | 3 |
| Countries | Iran (Islamic Republic of) |
| Conditions | end stage renal disease. Chronic kidney disease, stage 5;N18.5 |
| Interventions | Intervention 1: Intervention group: Oral aspirin 80 milligram tablet (from Jalinous company) will be taken daily for 1 year after right jugular permanent catheter placement, and the patency of the patient's catheter is evaluated by a… |
| Registration date | Apr 18, 2023 |
| Target size | 74 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: